Xcout IntelSign inSubscribe

OSTEOPORE LIMITED

OSXHealth Care Equipment & ServicesPerth, Australia

Established in Singapore in 2003, Osteopore Limited focuses on engineering, manufacturing, and globally commercializing bioresorbable polymer implants. These advanced devices are utilized in neurosurgical, orthopedic, and maxillofacial operations throughout Singapore, Australia, and other international regions. The company's core innovation involves employing 3D printing with bioresorbable materials to create custom, micro-structured scaffolds specifically designed to foster bone regeneration. Its product portfolio includes Osteoplug, a resorbable implant for sealing trephination burr holes during neurosurgery, and Osteomesh, another resorbable implant used in craniofacial surgery to mend various fractures, including orbital floor injuries, and to fill surgical voids. Additionally, Osteopore has forged a collaborative partnership with Livingstone Health Holding Limited to jointly pioneer new products and applications for bone and tissue regeneration.

Subscribe to see OSTEOPORE LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

OSTEOPORE LIMITED at a glance

OSTEOPORE LIMITED is a health care equipment & services company headquartered in Perth, Australia. It is publicly listed (OSX) with a market capitalisation of $891,359. Xcout tracks 5 named people at OSTEOPORE LIMITED, including Lim Yujing (Executive Director, Chief Executive Officer, Chief Technology Officer).

Industry
Health Care Equipment & Services
Headquarters
Perth, Australia
Market cap
$891,359
Employees
15
Ticker
OSX

OSTEOPORE LIMITED leadership

  • Lim YujingExecutive Director, Chief Executive Officer, Chief Technology Officer
  • Mark LeongExecutive Chairman
  • Voon Shu NingGroup Financial Controller
  • Michael KeenanNon-Executive Director
  • Teoh Swee HinNon-Executive Director

OSTEOPORE LIMITED competitors

A few of OSTEOPORE LIMITED's closest competitors — see the full list of competitors and alternatives →

RESONANCE HEALTH LIMITEDRHT · Health Care Equipment & ServicesBurswood, Australia
63% matchPublic

Resonance Health Limited is a global provider of healthcare technology and services, specializing in the design, development, and production of software-as-medical devices. The company serves markets across the Asia Pacific, Americas, Europe, Middle East, and Africa. Its portfolio of non-invasive, MRI-based diagnostic tools includes FerriScan, a system for quantifying liver iron concentration (LIC); FerriSmart, leveraging artificial intelligence (AI) for automated, real-time assessment of LIC; HepaFat-AI, an AI-driven solution for real-time, multi-metric liver fat quantification; CardiacT2, which provides dual analysis in conjunction with FerriScan to evaluate cardiac iron accumulation; HepaFat-Scan, a non-invasive MRI method for assessing liver fat within tissue; and LiverSmart, a comprehensive non-invasive MRI device integrating FerriSmart and HepaFat-AI for a unified report. The company further extends its offerings to include quantitative imaging measurements and Contract Research Organization (CRO) services, encompassing rigorous image analysis, imaging charter development, robust project and data management, proactive issue resolution, site tracking with clinical trial progress reports, and streamlined data flow coordination. They also provide comprehensive biomarker services, covering analysis of blood, urine, and protein analytes, alongside RNA, DNA, and genotyping. Their support for multinational and multicenter clinical trials extends to protocol development, subject inclusion/exclusion criteria assessment, dose modification strategies, new therapy safety profile evaluations, and establishing primary and secondary endpoints for drug efficacy. Additionally, they supply phantoms crucial for MRI machine calibration. Its client base includes clinicians, who utilize their solutions for managing human diseases, and pharmaceutical and therapeutic companies engaged in clinical research. Established in 1987, Resonance Health Limited maintains its headquarters in Burswood, Australia.

Market cap$18.7M
Employees18
RESONANCE HEALTH LIMITED competitors & alternatives →

Get OSTEOPORE LIMITED's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

OSTEOPORE LIMITED — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on OSTEOPORE LIMITED in Xcout Intel

  • 5 named people with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →